SignatureFD’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $936 | Sell |
544
-5,035
| -90% | -$8.66K | ﹤0.01% | 3021 |
|
2025
Q1 | $18.6K | Sell |
5,579
-2,648
| -32% | -$8.82K | ﹤0.01% | 2087 |
|
2024
Q4 | $60.9K | Sell |
8,227
-471
| -5% | -$3.49K | ﹤0.01% | 1471 |
|
2024
Q3 | $81.7K | Sell |
8,698
-522
| -6% | -$4.9K | ﹤0.01% | 1317 |
|
2024
Q2 | $73.9K | Sell |
9,220
-159
| -2% | -$1.28K | ﹤0.01% | 1310 |
|
2024
Q1 | $139K | Buy |
9,379
+656
| +8% | +$9.72K | ﹤0.01% | 1014 |
|
2023
Q4 | $70.9K | Buy |
8,723
+6,277
| +257% | +$51K | ﹤0.01% | 1299 |
|
2023
Q3 | $11.1K | Buy |
2,446
+1,479
| +153% | +$6.73K | ﹤0.01% | 2147 |
|
2023
Q2 | $6.81K | Buy |
967
+681
| +238% | +$4.79K | ﹤0.01% | 2404 |
|
2023
Q1 | $1.75K | Buy |
+286
| New | +$1.75K | ﹤0.01% | 2839 |
|
2022
Q3 | – | Sell |
-51
| Closed | -$1K | – | 3204 |
|
2022
Q2 | $1K | Sell |
51
-796
| -94% | -$15.6K | ﹤0.01% | 2924 |
|
2022
Q1 | $14K | Buy |
847
+227
| +37% | +$3.75K | ﹤0.01% | 1995 |
|
2021
Q4 | $12K | Buy |
620
+31
| +5% | +$600 | ﹤0.01% | 2025 |
|
2021
Q3 | $15K | Buy |
589
+273
| +86% | +$6.95K | ﹤0.01% | 1878 |
|
2021
Q2 | $8K | Buy |
316
+193
| +157% | +$4.89K | ﹤0.01% | 2081 |
|
2021
Q1 | $4K | Buy |
+123
| New | +$4K | ﹤0.01% | 2239 |
|
2020
Q3 | – | Sell |
-49
| Closed | -$1K | – | 2652 |
|
2020
Q2 | $1K | Buy |
+49
| New | +$1K | ﹤0.01% | 2306 |
|